ROSALIO GALLEGOS
Family Nurse Practitioner · SAN ANTONIO, TX
Individual Active NPI 1639718661
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 777 | 229,820 | $20,117,884 | $5,063,526 | $4,024,022 |
| 2023 | 981 | 271,358 | $23,471,643 | $6,161,200 | $4,889,080 |
| 2022 | 792 | 199,313 | $18,730,503 | $5,006,116 | $3,983,126 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | 29,190 | $11 | $9 |
| J0897 | Injection, denosumab, 1 mg | 25,200 | $25 | $20 |
| J1756 | Injection, iron sucrose, 1 mg | 15,300 | $0 | $0 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 15,000 | $1 | $1 |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 6,759 | $47 | $37 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 6,600 | $22 | $17 |
| J2182 | Injection, mepolizumab, 1 mg | 4,000 | $30 | $24 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 2,930 | $0 | $0 |
| J2357 | Injection, omalizumab, 5 mg | 2,595 | $37 | $30 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,160 | $31 | $25 |
| J9312 | Injection, rituximab, 10 mg | 1,690 | $64 | $51 |
| 96372 | Injection of drug or substance under skin or into muscle | 849 | $11 | $9 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | AP144406 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in Texas
- NPI 1639850274
- NPI 1447869540
- NPI 1366896888
- NPI 1881553360
- NPI 1568383081
- NPI 1225852148
- NPI 1427638162
- NPI 1033677414
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.